Elicera Therapeutics AB (OSTO:ELIC) Change In Other Working Capital : kr-3.52 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Elicera Therapeutics AB Change In Other Working Capital?

Elicera Therapeutics AB's Change In Other Working Capital for the quarter that ended in Mar. 2024 was kr-3.99 Mil. It means Elicera Therapeutics AB's Other Working Capital declined by kr3.99 Mil from Dec. 2023 to Mar. 2024 .

Elicera Therapeutics AB's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was kr0.27 Mil. It means Elicera Therapeutics AB's Other Working Capital increased by kr0.27 Mil from Dec. 2022 to Dec. 2023 .

Elicera Therapeutics AB Change In Other Working Capital Historical Data

The historical data trend for Elicera Therapeutics AB's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elicera Therapeutics AB Change In Other Working Capital Chart

Elicera Therapeutics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

2.35

0.15

11.01

0.27

Elicera Therapeutics AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Other Working Capital	Get a 7-Day Free Trial													-0.19	1.53	-7.84	6.78	-3.99

Elicera Therapeutics AB Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-3.52 Mil.

Elicera Therapeutics AB Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Elicera Therapeutics AB's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Elicera Therapeutics AB (OSTO:ELIC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elicera Therapeutics AB (OSTO:ELIC) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

8E8:Germany

Address

Massans gata 10, World Trade Center Goteborg, 7th Floor, Goteborg, SWE, SE-412 51

Website

https://www.elicera.com

Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments. The company's product portfolio consists of four drug candidates, two in the field of oncolytic viruses (ELC-100 and ELC-201) and two in the field of CAR T-cell treatments (ELC-301 and ELC-401), in addition to a universal CAR T-cell technology platform, iTANK (ELC-001), compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.

Elicera Therapeutics AB (OSTO:ELIC) Headlines

No Headlines